Erythropoietin Market

Erythropoietin Drugs Market (Drug Class - Epoetin Alfa, Epoetin Beta, and Darbepoetin Alfa; Drug Type - Biologics and Biosimilar; Drug Application - Cancer, Renal Disease, Hematology, Neurology, and Others (Surgery and Wound Healing); Distribution Channel - Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy - Global Industry Analysis, Size, Share, Volume, Growth, Trends, and Forecast 2017 - 2025

  • Rep Id : TMRGL1856
  • Published On : Dec 2017
  • No. of Pages : 237
  • Category : Pharmaceutical

Section 1 Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights 

Section 2 Assumptions and Research Methodology

Section 3 Executive Summary

Section 4 Market Overview
4.1. Introduction
        4.1.1. Product Type Definition
4.2. Overview
4.3. Market Dynamics 
        4.3.1. Drivers
                 4.3.1.1. Increase number of patients suffering from anemic condition
                 4.3.1.2. Increasing number of patients suffering from cancer
                 4.3.1.3. Increasing number of patients suffering from chronic kidney disease
                 4.3.1.4. Patent Expirations of Leading Erythropoietin Drugs
                 4.3.1.5. Rising demand for improved and advanced erythropoietin drugs products
                 4.3.1.6. Reimbursement policies for patients 
        4.3.2. Restraints
                 4.3.2.1. Highly priced erythropoietin drugs resulting in minimal adoption
                 4.3.2.2. High side effects of erythropoietin drugs
        4.3.3 Opportunities
4.4. Global Erythropoietin Drugs Market Forecast
4.5. Porter's Five Forces Analysis
4.6. Market Outlook
4.7. Challenges
        4.7.1. Cancer Worldwide
        4.7.2. Anaemia Worldwide
        4.7.3. Chronic Kidney Disease Worldwide
        4.7.4. Erythropoietin Pipeline Drugs
        4.7.5. Global Price of Erythropoietin Products
        4.7.6. Global Regulatory Status 
4.8. Heat Map Analysis 
4.9. Product Profiling for Leading Drugs
4.10. Epoetin alfa
4.11. Epoetin beta
4.12. Darbepoetin alfa
4.13. Others

Section 5 Global Erythropoietin Drugs Market Analysis, by Drug Class
5.1. Key Findings / Developments
5.2. Introduction & Definition 
5.3. Global Erythropoietin Drugs Market Value Share Analysis, by Drug Class
5.4. Global Erythropoietin Drugs Market Forecast, by Drug Class
5.5. Global Erythropoietin Drugs Market Analysis, by Drug Class 
        5.5.1. Epoetin Alfa
        5.5.2. Epoetin Beta        
        5.5.3. Darbepoetin Alfa
        5.5.4. Others
5.6. Global Erythropoietin Drugs Market Attractiveness, by Drug Class

Section 6 Global Erythropoietin Drugs Market Analysis, by Drug Type
6.1. Key Findings / Developments
6.2. Introduction & Definition 
6.3. Global Erythropoietin Drugs Market Value Share Analysis, by Drug Type
6.4. Global Erythropoietin Drugs Market Forecast, by Drug Type
6.5. Global Erythropoietin Drugs Market Analysis, by Drug Type
        6.5.1. Biologics
        6.5.2. Biosimilar
6.6. Global Erythropoietin Drugs Market Attractiveness, by Drug Type

Section 7 Global Erythropoietin Drugs Market Analysis, by Drug Type
7.1. Key Findings / Developments
7.2. Introduction & Definition 
7.3. Global Erythropoietin Drugs Market Value Share Analysis, by Distribution Channel
7.4. Global Erythropoietin Drugs Market Forecast, by Distribution Channel 
7.5. Global Erythropoietin Drugs Market Forecast, by Distribution Channel 
        7.5.1. Hospital Pharmacy
        7.5.2. Retail Pharmacy
        7.5.3. Online Pharmacy
7.6. Global Erythropoietin Drugs Market Attractiveness, by Distribution Channel

Section 8 Global Erythropoietin Drugs Market Analysis, by Drug Application
8.1. Key Findings / Developments
8.2. Introduction & Definition 
8.3. Global Erythropoietin Drugs Market Value Share Analysis, by Drug Application
8.4. Global Erythropoietin Drugs Market Forecast, by Drug Application 
8.5. Global Erythropoietin Drugs Market Analysis, by Drug Application
        8.5.1. Cancer
        8.5.2. Renal Disease
        8.5.3. Hematology
        8.5.3. Neurology
        8.5.4. Others
8.6. Global Erythropoietin Drugs Market Attractiveness, by Drug Application

Section 9 Global Erythropoietin Drugs Market Analysis, by Region
9.1. Global Erythropoietin Drugs Market
9.2. Introduction 
9.3. Global Erythropoietin Drugs Market Value Share Analysis, by Region
9.4. Global Erythropoietin Drugs Market Forecast, by Region
9.5. Global Erythropoietin Drugs Market Attractiveness, by Region

Section 10 North America Erythropoietin Drugs Market Analysis
10.1. Key Findings / Developments
10.2. North America Erythropoietin Drugs Market Overview
10.3. North America Erythropoietin Drugs Market Value Share Analysis, by Country
        10.3.1. U.S.
        10.3.2. Canada
10.4. North America Erythropoietin Drugs Market Forecast, by Country
10.5. North America Erythropoietin Drugs Market Value Share Analysis, by Drug Class
        10.5.1. Epoetin Alfa
        10.5.2. Epoetin Beta
        10.5.3. Darbepoetin Alfa
        10.5.4. Others
10.6. North America Erythropoietin Drugs Market Forecast, by Drug Class
10.7. North America Erythropoietin Drugs Market Value Share Analysis, by Distribution Channel
        10.7.1. Hospital Pharmacy
        10.7.2. Retail Pharmacy
        10.7.3. Online Pharmacy
10.8. North America Erythropoietin Drugs Market Forecast, by Distribution Channel
10.9. North America Erythropoietin Drugs Market Value Share Analysis, by Drug Type
        10.9.1. Biologics
        10.9.2. Biosimilar
10.10. North America Erythropoietin Drugs Market Forecast, by Drug Type
10.11. North America Erythropoietin Drugs Market Value Share Analysis, by Drug Application
        10.11.1. Cancer
        10.11.2. Renal Disease        
        10.11.3. Hematology
        10.11.4. Neurology
        10.11.5. Others (Surgery, Wound healing, etc.)
10.12. North America Erythropoietin Drugs Market Forecast, by Drug Application
10.13. North America Erythropoietin Drugs Market Attractiveness Analysis

Section 11 Europe Erythropoietin Drugs Market Analysis
11.1 Key Findings / Developments
11.2. Europe Erythropoietin Drugs Market Overview
11.3. Europe Erythropoietin Drugs Market Value Share Analysis, by Country/Sub-region
        11.3.1. Germany
        11.3.2. U.K.
        11.3.3. France
        11.3.4. Italy
        11.3.5. Spain
        11.3.6. Rest of Europe
11.4. Europe Erythropoietin Drugs Market Forecast, by Country
11.5. Europe Erythropoietin Drugs Market Value Share Analysis, by Drug Class
        11.5.1. Epoetin Alfa
        11.5.2. Epoetin Beta
        11.5.3. Darbepoetin Alfa
        11.5.4. Others
11.6. Europe Erythropoietin Drugs Market Forecast, by Drug Class
11.7. Europe Erythropoietin Drugs Market Value Share Analysis, by Distribution Channel
        11.7.1. Hospital Pharmacy
        11.7.2. Retail Pharmacy
        11.7.3. Online Pharmacy
11.8. Europe Erythropoietin Drugs Market Forecast, by Distribution Channel
11.9. Europe Erythropoietin Drugs Market Value Share Analysis, by Drug Type
        11.9.1. Biologics
        11.9.2. Biosimilar
11.10. Europe Erythropoietin Drugs Market Forecast, by Drug Type
11.11. Europe Erythropoietin Drugs Market Value Share Analysis, by Drug Application
        11.11.1. Cancer        
        11.11.2. Renal Disease
        11.11.3. Hematology
        11.11.4. Neurology
        11.11.5. Others (Surgery, Wound healing, etc.)
11.12. Europe Erythropoietin Drugs Market Forecast, by Drug Application
11.13. Europe Erythropoietin Drugs Market Attractiveness Analysis

Section 12 Asia Pacific Erythropoietin Drugs Market Analysis
12.1 Key Findings / Developments
12.2. Asia Pacific Erythropoietin Drugs Market Overview
12.3. Asia Pacific Erythropoietin Drugs Market Value Share Analysis, by Country/Sub-region
        12.3.1. Japan
        12.3.2. China
        12.3.3. India
        12.3.4. Australia & New Zealand
        12.3.5. Rest of APAC
12.4. Asia Pacific Erythropoietin Drugs Market Forecast, by Country
12.5. Asia Pacific Erythropoietin Drugs Market Value Share Analysis, by Drug Class
        12.5.1. Epoetin Alfa
        12.5.2. Epoetin Beta
        12.5.3. Darbepoetin Alfa
        12.5.4. Others
12.6. Asia Pacific Erythropoietin Drugs Market Forecast, by Drug Class
12.7. Asia Pacific Erythropoietin Drugs Market Value Share Analysis, by Distribution Channel
        12.7.1. Hospital Pharmacy
        12.7.2. Retail Pharmacy
        12.7.3. Online Pharmacy
12.8. Asia Pacific Erythropoietin Drugs Market Forecast, by Distribution Channel
12.9. Asia Pacific Erythropoietin Drugs Market Value Share Analysis, by Drug Type
        12.9.1. Biologics
        12.9.2. Biosimilar
12.10. Asia Pacific Erythropoietin Drugs Market Forecast, by Drug Type
12.11. Asia Pacific Erythropoietin Drugs Market Value Share Analysis, by Drug Application
        12.11.1. Cancer
        12.11.2. Renal Disease
        12.11.3. Hematology
        12.11.4. Neurology
        12.11.5. Others (Surgery, Wound healing, etc.)
12.12. Asia Pacific Erythropoietin Drugs Market Forecast, by Drug Application
12.13. Asia Pacific Erythropoietin Drugs Market Attractiveness Analysis

Section 13 Asia Pacific Erythropoietin Drugs Market Analysis
13.1 Key Findings / Developments
13.2. Latin America Erythropoietin Drugs Market Overview
13.3. Latin America Erythropoietin Drugs Market Value Share Analysis, by Country/Sub-region
        13.3.1. Brazil
        13.3.2. Mexico
        13.3.3. Rest of LA
13.4. Latin America Erythropoietin Drugs Market Forecast, by Country
13.5. Latin America Erythropoietin Drugs Market Value Share Analysis, by Drug Class
        13.5.1. Epoetin Alfa
        13.5.2. Epoetin Beta
        13.5.3. Darbepoetin Alfa
        13.5.4. Others
13.6. Latin America Erythropoietin Drugs Market Forecast, by Drug Class
13.7. Latin America Erythropoietin Drugs Market Value Share Analysis, by Distribution Channel
        13.7.1. Hospital Pharmacy
        13.7.2. Retail Pharmacy
        13.7.3 Online Pharmacy
13.8. Latin America Erythropoietin Drugs Market Forecast, by Distribution Channel
13.9. Latin America Erythropoietin Drugs Market Value Share Analysis, by Drug Type
        13.9.1. Biologics
        13.9.2. Biosimilar
13.10. Latin America Erythropoietin Drugs Market Forecast, by Drug Type
13.11. Latin America Erythropoietin Drugs Market Value Share Analysis, by Drug Application
        13.11.1. Cancer
        13.11.2. Renal Disease
        13.11.3. Hematology
        13.11.4. Neurology
        13.11.5. Others (Surgery, Wound healing, etc.)
13.12. Latin America Erythropoietin Drugs Market Forecast, by Drug Application
13.13. Latin America Erythropoietin Drugs Market Attractiveness Analysis

Section 14 Middle East & Africa Erythropoietin Drugs Market Analysis
14.1. Key Findings / Developments
14.2. Middle East & Africa Erythropoietin Drugs Market Overview
14.3. Middle East & Africa Erythropoietin Drugs Market Value Share Analysis, by Country/Sub-region
        14.3.1. GCC Countries
        14.3.2. South Africa
        14.3.3. Israel
        14.3.4. Rest of MEA
14.4. Middle East & Africa Erythropoietin Drugs Market Forecast, by Country
14.5. Middle East & Africa Erythropoietin Drugs Market Value Share Analysis, by Drug Class
        14.5.1. Epoetin Alfa
        14.5.2. Epoetin Beta
        14.5.3. Darbepoetin Alfa
        14.5.4. Others
14.6. Middle East & Africa Erythropoietin Drugs Market Forecast, by Drug Class
14.7. Middle East & Africa Erythropoietin Drugs Market Value Share Analysis, by Distribution Channel
        14.7.1. Hospital Pharmacy
        14.7.2. Retail Pharmacy
        14.7.3 Online Pharmacy
14.8. Middle East & Africa Erythropoietin Drugs Market Forecast, by Distribution Channel
14.9. Middle East & Africa Erythropoietin Drugs Market Value Share Analysis, by Drug Type
        14.9.1. Biologics
        14.9.2. Biosimilar
14.10. Middle East & Africa Erythropoietin Drugs Market Forecast, by Drug Type
14.11. Middle East & Africa Erythropoietin Drugs Market Value Share Analysis, by Drug Application
        14.11.1. Cancer
        14.11.2. Renal Disease
        14.11.3. Hematology
        14.11.4. Neurology
        14.11.5. Others (Surgery, Wound healing, etc.)
14.12. Middle East & Africa Erythropoietin Drugs Market Forecast, by Drug Application
14.13. Middle East & Africa Erythropoietin Drugs Market Attractiveness Analysis

List of Tables

Table 01: Most common type of cancer with number of deaths in 2015
Table 02: Ranking of anemia prevalence worldwide
Table 03: Ranking of annual mortality rate by chronic kidney disease in 2013 
Table 04: Erythropoietin Pipeline Drugs
Table 05: Erythropoietin Stimulating Agents Price 2015-2016
Table 06: Regulatory Status 2015-2016
Table 07: Global Erythropoietin Drugs Market Size (US$ Mn) Forecast, by Drug Class, 2015–2025
Table 08: Global Erythropoietin Drugs Market Size (US$ Mn) Forecast, by Drug Type, 2015–2025
Table 09: Global Erythropoietin Drugs Market Value (US$ Mn) Forecast, by Distribution Channel, 2015–2025
Table 10: Global Erythropoietin Drugs Market Value (US$ Mn) Forecast, by Drug Application, 2015–2025
Table 11: Global Erythropoietin Drugs Market Size (US$ Mn) Forecast, by Region, 2015–2025
Table 12: North America Erythropoietin Drugs Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 13: North America Erythropoietin Drugs Market Size (US$ Mn) Forecast, by Drug Class, 2015–2025
Table 14: North America Erythropoietin Drugs Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025
Table 15: North America Erythropoietin Drugs Market Size (US$ Mn) Forecast, by Drug Type, 2015–2025
Table 16: North America Erythropoietin Drugs Market Size (US$ Mn) Forecast, by Drug Application, 2015–2025
Table 17: Europe Erythropoietin Drugs Market Size (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
Table 18: Europe Erythropoietin Drugs Market Size (US$ Mn) Forecast, by Drug Class, 2015–2025
Table 19: Europe Erythropoietin Drugs Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025
Table 20: Europe Erythropoietin Drugs Market Size (US$ Mn) Forecast, by Drug Type, 2015–2025
Table 21: Europe Erythropoietin Drugs Market Size (US$ Mn) Forecast, by Drug Application, 2015–2025
Table 22: Asia Pacific Erythropoietin Drugs Market Size (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
Table 23: Asia Pacific Erythropoietin Drugs Market Size (US$ Mn) Forecast, by Drug Class, 2015–2025
Table 24: Asia Pacific Erythropoietin Drugs Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025
Table 25: Asia Pacific Erythropoietin Drugs Market Size (US$ Mn) Forecast, by Drug Type, 2015–2025
Table 26: Asia Pacific Erythropoietin Drugs Market Size (US$ Mn) Forecast, by Drug Application, 2015–2025
Table 27: Latin America Erythropoietin Drugs Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 28: Latin America Erythropoietin Drugs Market Size (US$ Mn) Forecast, by Drug Class, 2015–2025
Table 29: Latin America Erythropoietin Drugs Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025
Table 30: Latin America Erythropoietin Drugs Market Size (US$ Mn) Forecast, by Drug Type, 2015–2025
Table 31: Latin America Erythropoietin Drugs Market Size (US$ Mn) Forecast, by Drug Application, 2015–2025
Table 32: Middle East & Africa Erythropoietin Drugs Market Size (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
Table 33: Middle East & Africa Erythropoietin Drugs Market Size (US$ Mn) Forecast, by Drug Class, 2015–2025
Table 34: Middle East & Africa Erythropoietin Drugs Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025
Table 35: Middle East & Africa Erythropoietin Drugs Market Size (US$ Mn) Forecast, by Drug Type, 2015–2025
Table 36: Middle East & Africa Erythropoietin Drugs Market Size (US$ Mn) Forecast, by Drug Application, 2015–2025

List of Figures

Figure 01: Global Erythropoietin Drugs Market Size (US$ Mn) and Distribution, by Geography, 2016 and 2025
Figure 02: Global Erythropoietin Drugs Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2025
Figure 03: Global Erythropoietin Drugs Market Value Share, by Drug Class (2016)
Figure 04: Global Erythropoietin Drugs Market Value Share, by Distribution Channel (2016)
Figure 05: Global Erythropoietin Drugs Market Value Share, by Region (2016)
Figure 06: World cancer prevalence
Figure 07: World anemia prevalence (Preschool age children)
Figure 08: World chronic kidney disease prevalence 
Figure 09: Global Erythropoietin Drugs Market Value Share Analysis, by Drug Class, 2016 and 2025
Figure 10: Global Erythropoietin Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Epoetin Alfa, 2015–2025
Figure 11: Global Erythropoietin Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Epoetin Beta, 2015–2025
Figure 12: Global Erythropoietin Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Darbepoetin Alfa, 2015–2025
Figure 13: Global Erythropoietin Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Others, 2015–2025
Figure 14: Global Erythropoietin Drugs Market Attractiveness, by Drug Class, 2017–2025
Figure 15: Global Erythropoietin Drugs Market Value Share Analysis, by Drug Type, 2016 and 2025
Figure 16: Global Erythropoietin Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Biologics, 2015–2025
Figure 17: Global Erythropoietin Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Biosimilar, 2015–2025
Figure 18: Global Erythropoietin Drugs Market Attractiveness, by Drug Class, 2017–2025
Figure 19: Global Erythropoietin Drugs Market Value Share Analysis, by Distribution Channel, 2016 and 2025
Figure 20: Global Erythropoietin Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hospital Pharmacy, 2015–2025
Figure 21: Global Erythropoietin Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Retail Pharmacy, 2015–2025
Figure 22: Europe Global Erythropoietin Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Physician’s Office Laboratories, 2015–2025
Figure 23: Global Erythropoietin Drugs Market Attractiveness, by Distribution Channel, 2017-2025
Figure 24: Global Erythropoietin Drugs Market Value Share Analysis, by Drug Application, 2016 and 2025
Figure 25: Global Erythropoietin Drugs Market Revenue (US$ Bn) and Y-o-Y Growth (%) Forecast, by Cancer, 2015–2025
Figure 26: Global Erythropoietin Drugs Market Revenue (US$ Bn) and Y-o-Y Growth (%) Forecast, by Renal Disease, 2015–2025
Figure 27: Global Erythropoietin Drugs Market Revenue (US$ Bn) and Y-o-Y Growth (%) Forecast, by Hematology, 2015–2025
Figure 28: Global Erythropoietin Drugs Market Revenue (US$ Bn) and Y-o-Y Growth (%) Forecast, by Neurology, 2015–2025
Figure 29: Europe Global Erythropoietin Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2015–2025
Figure 30: Global Erythropoietin Drugs Market Attractiveness, by Drug Application, 2017-2025
Figure 31: Global Erythropoietin Drugs Market Revenue (US$ Mn) Forecast, 2015–2025
Figure 32: Global Erythropoietin Drugs Market Value Share Analysis, by Region, 2016 and 2025
Figure 33: Global Erythropoietin Drugs Market Attractiveness, by Region, 2017-2025
Figure 34: North America Erythropoietin Drugs Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2015–2025
Figure 35: North America Erythropoietin Drugs Market Attractiveness Analysis, by Country, 2017–2025
Figure 36: North America Erythropoietin Drugs Market Value Share Analysis, by Country, 2016 and 2025
Figure 37: North America Erythropoietin Drugs Market Value Share Analysis, by Drug Class, 2016 and 2025
Figure 38: North America Erythropoietin Drugs Market Value Share Analysis, by Distribution Channel, 2016 and 2025
Figure 39: North America Erythropoietin Drugs Market Value Share Analysis, by Drug Type, 2016 and 2025
Figure 40: North America Erythropoietin Drugs Market Value Share Analysis, by Drug Application, 2016 and 2025
Figure 41: North America Erythropoietin Drugs Market Attractiveness Analysis, by Drug Type, 2017–2025
Figure 42: North America Erythropoietin Drugs Market Attractiveness Analysis, by Distribution Channel, 2017–2025
Figure 43: North America Erythropoietin Drugs Market Attractiveness Analysis, by Drug Application, 2017–2025
Figure 44: Europe Erythropoietin Drugs Market Size (US$ Mn) Forecast, 2015–2025
Figure 45: Europe Erythropoietin Drugs Market Attractiveness Analysis, by Country/Sub-region, 2017–2025
Figure 46: Europe Erythropoietin Drugs Market Value Share Analysis, by Country/Sub-region, 2016 and 2025
Figure 47: Europe Erythropoietin Drugs Market Value Share Analysis, by Drug Class, 2016 and 2025
Figure 48: Europe Erythropoietin Drugs Market Value Share Analysis, by Distribution Channel, 2016 and 2025
Figure 49: Europe Erythropoietin Drugs Market Value Share Analysis, by Drug Type, 2016 and 2025
Figure 50: Europe Erythropoietin Drugs Market Value Share Analysis, by Drug Application, 2016 and 2025
Figure 51: Europe Erythropoietin Drugs Market Attractiveness Analysis, by Drug Type, 2017–2025
Figure 52: Europe Erythropoietin Drugs Market Attractiveness Analysis, by Distribution Channel, 2017–2025
Figure 53: Europe Erythropoietin Drugs Market Attractiveness Analysis, by Drug Application, 2017–2025
Figure 54: Asia Pacific Erythropoietin Drugs Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2015–2025
Figure 55: Asia Pacific Erythropoietin Drugs Market Attractiveness Analysis, by Country/Sub-region, 2017–2025
Figure 56: Asia Pacific Erythropoietin Drugs Market Value Share Analysis, by Country/Sub-region, 2016 and 2025
Figure 57: Asia Pacific Erythropoietin Drugs Market Value Share Analysis, by Drug Class, 2016 and 2025
Figure 58: Asia Pacific Erythropoietin Drugs Market Value Share Analysis, by Distribution Channel, 2016 and 2025
Figure 59: Asia Pacific Erythropoietin Drugs Market Value Share Analysis, by Drug Type, 2016 and 2025
Figure 60: Asia Pacific Erythropoietin Drugs Market Value Share Analysis, by Drug Application, 2016 and 2025
Figure 61: Asia Pacific Erythropoietin Drugs Market Attractiveness Analysis, by Drug Type, 2017–2025
Figure 62: Asia Pacific Erythropoietin Drugs Market Attractiveness Analysis, by Distribution Channel, 2017–2025
Figure 63: Asia Pacific Erythropoietin Drugs Market Attractiveness Analysis, by Drug Application, 2017–2025
Figure 64: Latin America Erythropoietin Drugs Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2015–2025
Figure 65: Latin America Erythropoietin Drugs Market Attractiveness Analysis, by Country, 2017–2025
Figure 66: Latin America Erythropoietin Drugs Market Value Share Analysis, by Country, 2016 and 2025
Figure 67: Latin America Erythropoietin Drugs Market Value Share Analysis, by Drug Class, 2016 and 2025
Figure 68: Latin America Erythropoietin Drugs Market Value Share Analysis, by Distribution Channel, 2016 and 2025
Figure 69: Latin America Erythropoietin Drugs Market Value Share Analysis, by Drug Type, 2016 and 2025
Figure 70: Latin America Erythropoietin Drugs Market Value Share Analysis, by Drug Application, 2016 and 2025
Figure 71: Latin America Erythropoietin Drugs Market Attractiveness Analysis, by Drug Type, 2017–2025
Figure 72: Latin America Erythropoietin Drugs Market Attractiveness Analysis, by Distribution Channel, 2017–2025
Figure 73: Latin America Erythropoietin Drugs Market Attractiveness Analysis, by Drug Application, 2017–2025
Figure 74: Middle East & Africa Erythropoietin Drugs Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2015–2025
Figure 75: Middle East & Africa Erythropoietin Drugs Market Attractiveness Analysis, by Country/Sub-region, 2017–2025
Figure 76: Middle East & Africa Erythropoietin Drugs Market Value Share Analysis, by Country/Sub-region, 2016 and 2025
Figure 77: Middle East & Africa Erythropoietin Drugs Market Value Share Analysis, by Drug Class, 2016 and 2025
Figure 78: Middle East & Africa Erythropoietin Drugs Market Value Share Analysis, by Distribution Channel, 2016 and 2025
Figure 79: Middle East & Africa Erythropoietin Drugs Market Value Share Analysis, by Drug Type, 2016 and 2025
Figure 80: Middle East & Africa Erythropoietin Drugs Market Value Share Analysis, by Drug Application, 2016 and 2025
Figure 81: Middle East & Africa Erythropoietin Drugs Market Attractiveness Analysis, by Drug Type, 2017–2025
Figure 82: Middle East & Africa Erythropoietin Drugs Market Attractiveness Analysis, by Distribution Channel, 2017–2025
Figure 83: Middle East & Africa Erythropoietin Drugs Market Attractiveness Analysis, by Drug Application, 2017–2025

.